HIGHLIGHTS
- What: This study explored their synergistic effects on allcause and cardiovascular death in AMI patients, aiming to advance integrated risk management strategies for high-risk populations. Sensitivity analysis was conducted to evaluate the stability of these associations, particularly after excluding patients with an eGFR and amp;lt; 30 ml/min/ 1.73m2. Although this study has revealed the synergistic effect of Lp(a) and HsCRP on the risk of all-cause and cardiovascular mortality in AMI patients, Hs-CRP may indicate the need for anti-inflammatory medications such as colchicine.
- Who: Oscar Lorenzo et al . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.